Eagle Pharmaceuticals Profit Margin 2013-2018 | EGRX
Current and historical gross margin, operating margin and net profit margin for Eagle Pharmaceuticals (EGRX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Eagle Pharmaceuticals net profit margin as of December 31, 2018 is 14.96%.
|Eagle Pharmaceuticals Annual Profit Margins
|Eagle Pharmaceuticals Quarterly Profit Margins
||Medical Products Manufacturing
Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The Company markets EP-1101 to treat heparin-induced thrombocytopenia. It develops EP-3101, EP-3102, Ryanodex and EP-4104. Eagle Pharmaceuticals, Inc. is based in Woodcliff Lake, New Jersey.